BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03829332-completion@plaintrial.com
DTSTAMP:20261029T034721Z
DTSTART;VALUE=DATE:20240424
SUMMARY:Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Withou
 t Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1
  (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7
 902-007/E7080-G000-314/LEAP-007) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03829332
URL:https://plaintrial.com/trial/NCT03829332
END:VEVENT
END:VCALENDAR